BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gao D, Herman JG, Guo M. The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancer. Oncotarget 2016;7:37331-46. [PMID: 26967246 DOI: 10.18632/oncotarget.7949] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 12.8] [Reference Citation Analysis]
Number Citing Articles
1 Perri F, Longo F, Giuliano M, Sabbatino F, Favia G, Ionna F, Addeo R, Della Vittoria Scarpati G, Di Lorenzo G, Pisconti S. Epigenetic control of gene expression: Potential implications for cancer treatment. Crit Rev Oncol Hematol 2017;111:166-72. [PMID: 28259291 DOI: 10.1016/j.critrevonc.2017.01.020] [Cited by in Crossref: 67] [Cited by in F6Publishing: 67] [Article Influence: 13.4] [Reference Citation Analysis]
2 Xue Y, Chen R, Du W, Yang F, Wei X. RIZ1 and histone methylation status in pituitary adenomas. Tumour Biol 2017;39:1010428317711794. [PMID: 28718376 DOI: 10.1177/1010428317711794] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
3 Mijnes J, Veeck J, Gaisa NT, Burghardt E, de Ruijter TC, Gostek S, Dahl E, Pfister D, Schmid SC, Knüchel R, Rose M. Promoter methylation of DNA damage repair (DDR) genes in human tumor entities: RBBP8/CtIP is almost exclusively methylated in bladder cancer. Clin Epigenetics 2018;10:15. [PMID: 29445424 DOI: 10.1186/s13148-018-0447-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
4 Porkka N, Valo S, Nieminen TT, Olkinuora A, Mäki-Nevala S, Eldfors S, Peltomäki P. Sequencing of Lynch syndrome tumors reveals the importance of epigenetic alterations. Oncotarget 2017;8:108020-30. [PMID: 29296220 DOI: 10.18632/oncotarget.22445] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
5 Oleksiewicz U, Machnik M. Causes, effects, and clinical implications of perturbed patterns within the cancer epigenome. Semin Cancer Biol 2020:S1044-579X(20)30274-1. [PMID: 33359485 DOI: 10.1016/j.semcancer.2020.12.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Kejík Z, Kaplánek R, Havlík M, Bříza T, Jakubek M, Králová J, Mikula I, Martásek P, Král V. Optical probes and sensors as perspective tools in epigenetics. Bioorg Med Chem 2017;25:2295-306. [PMID: 28285925 DOI: 10.1016/j.bmc.2017.01.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
7 Morotti A, Rocca S, Carrà G, Saglio G, Brancaccio M. Modeling myeloproliferative neoplasms: From mutations to mouse models and back again. Blood Rev 2017;31:139-50. [PMID: 27899218 DOI: 10.1016/j.blre.2016.11.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
8 Nascimento EFR, Ribeiro ML, Magro DO, Carvalho J, Kanno DT, Martinez CAR, Coy CSR. TISSUE EXPRESION OF THE GENES MUTYH AND OGG1 IN PATIENTS WITH SPORADIC COLORECTAL CANCER. Arq Bras Cir Dig 2017;30:98-102. [PMID: 29257843 DOI: 10.1590/0102-6720201700020005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
9 Šimoničová K, Janotka Ľ, Kavcová H, Sulová Z, Breier A, Messingerova L. Different mechanisms of drug resistance to hypomethylating agents in the treatment of myelodysplastic syndromes and acute myeloid leukemia. Drug Resistance Updates 2022. [DOI: 10.1016/j.drup.2022.100805] [Reference Citation Analysis]
10 Ortega-Bernal D, La Rosa CHG, Arechaga-Ocampo E, Alvarez-Avitia MA, Moreno NS, Rangel-Escareño C. A meta-analysis of transcriptome datasets characterizes malignant transformation from melanocytes and nevi to melanoma. Oncol Lett 2018;16:1899-911. [PMID: 30008882 DOI: 10.3892/ol.2018.8861] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
11 Li Q, Guan R, Qiao Y, Liu C, He N, Zhang X, Jia X, Sun H, Yu J, Xu L. Association between the BRCA2 rs144848 polymorphism and cancer susceptibility: a meta-analysis. Oncotarget 2017;8:39818-32. [PMID: 28418854 DOI: 10.18632/oncotarget.16242] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
12 Kamel HFM, Al-Amodi HSAB. Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine. Genomics Proteomics Bioinformatics 2017;15:220-35. [PMID: 28813639 DOI: 10.1016/j.gpb.2016.11.005] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 8.6] [Reference Citation Analysis]
13 Losi L, Fonda S, Saponaro S, Chelbi ST, Lancellotti C, Gozzi G, Alberti L, Fabbiani L, Botticelli L, Benhattar J. Distinct DNA Methylation Profiles in Ovarian Tumors: Opportunities for Novel Biomarkers. Int J Mol Sci 2018;19:E1559. [PMID: 29882921 DOI: 10.3390/ijms19061559] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
14 Casalino L, Verde P. Multifaceted Roles of DNA Methylation in Neoplastic Transformation, from Tumor Suppressors to EMT and Metastasis. Genes (Basel) 2020;11:E922. [PMID: 32806509 DOI: 10.3390/genes11080922] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
15 Gao A, Guo M. Epigenetic based synthetic lethal strategies in human cancers. Biomark Res 2020;8:44. [PMID: 32974031 DOI: 10.1186/s40364-020-00224-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
16 Kim S, Hwang SH, Im SG, Lee MK, Lee CH, Son SJ, Oh HB. Upconversion Nanoparticle-Based Förster Resonance Energy Transfer for Detecting DNA Methylation. Sensors (Basel) 2016;16:E1259. [PMID: 27517925 DOI: 10.3390/s16081259] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
17 Saikia S, Rehman AU, Barooah P, Sarmah P, Bhattacharyya M, Deka M, Deka M, Goswami B, Husain SA, Medhi S. Alteration in the expression of MGMT and RUNX3 due to non-CpG promoter methylation and their correlation with different risk factors in esophageal cancer patients. Tumour Biol 2017;39:1010428317701630. [PMID: 28468586 DOI: 10.1177/1010428317701630] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
18 Zeng JH, Liang L, He RQ, Tang RX, Cai XY, Chen JQ, Luo DZ, Chen G. Comprehensive investigation of a novel differentially expressed lncRNA expression profile signature to assess the survival of patients with colorectal adenocarcinoma. Oncotarget. 2017;8:16811-16828. [PMID: 28187432 DOI: 10.18632/oncotarget.15161] [Cited by in Crossref: 56] [Cited by in F6Publishing: 60] [Article Influence: 11.2] [Reference Citation Analysis]
19 Myasoedova VA, Sukhorukov V, Grechko AV, Zhang D, Romanenko E, Orekhov V, Orekhov AN. Inhibitors of DNA Methylation and Histone Deacetylation as Epigenetically Active Drugs for Anticancer Therapy. Curr Pharm Des 2019;25:635-41. [PMID: 30950345 DOI: 10.2174/1381612825666190405144026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
20 Babaei K, Khaksar R, Zeinali T, Hemmati H, Bandegi A, Samidoust P, Ashoobi MT, Hashemian H, Delpasand K, Talebinasab F, Naebi H, Mirpour SH, Keymoradzadeh A, Norollahi SE. Epigenetic profiling of MUTYH, KLF6, WNT1 and KLF4 genes in carcinogenesis and tumorigenesis of colorectal cancer. Biomedicine (Taipei) 2019;9:22. [PMID: 31724937 DOI: 10.1051/bmdcn/2019090422] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
21 Grimm C, Fischer A, Farrelly AM, Kalachand R, Castiglione R, Wasserburger E, Hussong M, Schultheis AM, Altmüller J, Thiele H, Reinhardt HC, Hauschulz K, Hennessy BT, Herwig R, Lienhard M, Buettner R, Schweiger MR. Combined Targeted Resequencing of Cytosine DNA Methylation and Mutations of DNA Repair Genes with Potential Use for Poly(ADP-Ribose) Polymerase 1 Inhibitor Sensitivity Testing. J Mol Diagn 2019;21:198-213. [PMID: 30576872 DOI: 10.1016/j.jmoldx.2018.10.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
22 Przybycinski J, Nalewajska M, Marchelek-Mysliwiec M, Dziedziejko V, Pawlik A. Poly-ADP-ribose polymerases (PARPs) as a therapeutic target in the treatment of selected cancers. Expert Opin Ther Targets 2019;23:773-85. [PMID: 31394942 DOI: 10.1080/14728222.2019.1654458] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
23 Rizzolo P, Silvestri V, Valentini V, Zelli V, Zanna I, Masala G, Bianchi S, Palli D, Ottini L. Gene-specific methylation profiles in BRCA-mutation positive and BRCA-mutation negative male breast cancers. Oncotarget 2018;9:19783-92. [PMID: 29731982 DOI: 10.18632/oncotarget.24856] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
24 Guffanti F, Fratelli M, Ganzinelli M, Bolis M, Ricci F, Bizzaro F, Chilà R, Sina FP, Fruscio R, Lupia M, Cavallaro U, Cappelletti MR, Generali D, Giavazzi R, Damia G. Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenografts. Oncotarget 2018;9:24707-17. [PMID: 29872499 DOI: 10.18632/oncotarget.25185] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
25 Yan W, Wu K, Herman JG, Xu X, Yang Y, Dai G, Guo M. Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer. Clin Epigenetics 2018;10:69. [PMID: 29796120 DOI: 10.1186/s13148-018-0501-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
26 Bartosch C, Lopes JM, Jerónimo C. Epigenetics in endometrial carcinogenesis - part 2: histone modifications, chromatin remodeling and noncoding RNAs. Epigenomics 2017;9:873-92. [PMID: 28523964 DOI: 10.2217/epi-2016-0167] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
27 Hsi E, Wang YS, Huang CW, Yu ML, Juo SH, Liang CL. Genome-wide DNA hypermethylation and homocysteine increase a risk for myopia. Int J Ophthalmol 2019;12:38-45. [PMID: 30662838 DOI: 10.18240/ijo.2019.01.06] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
28 Watson MM, Søreide K. The Gut Microbiota Influence on Human Epigenetics, Health, and Disease. Handbook of Epigenetics. Elsevier; 2017. pp. 495-510. [DOI: 10.1016/b978-0-12-805388-1.00032-8] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
29 Kwiatkowska M, Reszka E, Woźniak K, Jabłońska E, Michałowicz J, Bukowska B. DNA damage and methylation induced by glyphosate in human peripheral blood mononuclear cells (in vitro study). Food Chem Toxicol 2017;105:93-8. [PMID: 28351773 DOI: 10.1016/j.fct.2017.03.051] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 9.0] [Reference Citation Analysis]
30 Wang J, Wang Y, Long F, Yan F, Wang N, Wang Y. The expression and clinical significance of GADD45A in breast cancer patients. PeerJ 2018;6:e5344. [PMID: 30128181 DOI: 10.7717/peerj.5344] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
31 Hu Y, Guo M. Synthetic lethality strategies: Beyond BRCA1/2 mutations in pancreatic cancer. Cancer Sci 2020;111:3111-21. [PMID: 32639661 DOI: 10.1111/cas.14565] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
32 Domagala P, Hybiak J, Rys J, Byrski T, Cybulski C, Lubinski J. Pathological complete response after cisplatin neoadjuvant therapy is associated with the downregulation of DNA repair genes in BRCA1-associated triple-negative breast cancers. Oncotarget 2016;7:68662-73. [PMID: 27626685 DOI: 10.18632/oncotarget.11900] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
33 Dylawerska A, Barczak W, Wegner A, Golusinski W, Suchorska WM. Association of DNA repair genes polymorphisms and mutations with increased risk of head and neck cancer: a review. Med Oncol 2017;34:197. [PMID: 29143133 DOI: 10.1007/s12032-017-1057-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
34 Wang Y, Zhang M, Hu X, Qin W, Wu H, Wei M. Colon cancer-specific diagnostic and prognostic biomarkers based on genome-wide abnormal DNA methylation. Aging (Albany NY) 2020;12:22626-55. [PMID: 33202377 DOI: 10.18632/aging.103874] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Xie J, Fu L, Zhang J, Pandurangan A. Analysis of Influencing Factors on the Occurrence and Development of Gastric Cancer in High-Incidence Areas of Digestive Tract Tumors Based on High Methylation of GPX3 Gene. Journal of Oncology 2022;2022:1-9. [DOI: 10.1155/2022/3094881] [Reference Citation Analysis]
36 Wang Y, Liu H, Liu X, Zhang X, Wu J, Yuan L, Du X, Wang R, Ma Y, Chen X, Cheng X, Zhuang D, Zhang H. Histone acetylation plays an important role in MC-LR-induced apoptosis and cycle disorder in SD rat testicular cells. Chemosphere 2020;241:125073. [PMID: 31683423 DOI: 10.1016/j.chemosphere.2019.125073] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
37 Dong Y, Gao X, Zhao Y, Wei M, Xu L, Yang G, Liu L. Semi‑random mutagenesis profile of BCR‑ABL during imatinib resistance acquirement in K562 cells. Mol Med Rep 2017;16:9409-14. [PMID: 29152650 DOI: 10.3892/mmr.2017.7835] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
38 Zheng R, Gao D, He T, Zhang M, Zhang X, Linghu E, Wei L, Guo M. Methylation of DIRAS1 promotes colorectal cancer progression and may serve as a marker for poor prognosis. Clin Epigenetics. 2017;9:50. [PMID: 28491151 DOI: 10.1186/s13148-017-0348-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
39 He T, Zhang M, Zheng R, Zheng S, Linghu E, Herman JG, Guo M. Methylation of SLFN11 is a marker of poor prognosis and cisplatin resistance in colorectal cancer. Epigenomics 2017;9:849-62. [DOI: 10.2217/epi-2017-0019] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
40 Wu W, Klockow JL, Zhang M, Lafortune F, Chang E, Jin L, Wu Y, Daldrup-Link HE. Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance. Pharmacol Res 2021;171:105780. [PMID: 34302977 DOI: 10.1016/j.phrs.2021.105780] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Wu W, Bai S, Zhu D, Li K, Dong W, He W, Peng S, Lai Y, Wang Q, Guo Z, Liu L, Huang H. Overexpression of malignant brain tumor domain containing protein 1 predicts a poor prognosis of prostate cancer. Oncol Lett 2019;17:4640-6. [PMID: 30944653 DOI: 10.3892/ol.2019.10109] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Kottorou AE, Dimitrakopoulos FD, Antonacopoulou AG, Diamantopoulou G, Tsoumas D, Koutras A, Makatsoris T, Stavropoulos M, Thomopoulos KC, Hulbert A, Tzelepi V, Kalofonos HP. Differentially Methylated Ultra-Conserved Regions Uc160 and Uc283 in Adenomas and Adenocarcinomas Are Associated with Overall Survival of Colorectal Cancer Patients. Cancers (Basel) 2020;12:E895. [PMID: 32272654 DOI: 10.3390/cancers12040895] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Liu F, Jia J, Sun L, Yu Q, Duan H, Jiao D, Gong Z, Zhu S, Jiang K, He Y, Chen L, Zhang Y, Sun H. lncRNA DSCAM-AS1 downregulates miR-216b to promote the migration and invasion of colorectal adenocarcinoma cells. Onco Targets Ther 2019;12:6789-95. [PMID: 31686837 DOI: 10.2147/OTT.S213301] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
44 Jasek K, Kubatka P, Samec M, Liskova A, Smejkal K, Vybohova D, Bugos O, Biskupska-Bodova K, Bielik T, Zubor P, Danko J, Adamkov M, Kwon TK, Büsselberg D. DNA Methylation Status in Cancer Disease: Modulations by Plant-Derived Natural Compounds and Dietary Interventions. Biomolecules 2019;9:E289. [PMID: 31323834 DOI: 10.3390/biom9070289] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
45 Cao Y, Liu H, Li H, Lin C, Li R, Wu S, Zhang H, He H, Zhang W, Xu J. Association of O6-Methylguanine-DNA Methyltransferase Protein Expression With Postoperative Prognosis and Adjuvant Chemotherapeutic Benefits Among Patients With Stage II or III Gastric Cancer. JAMA Surg 2017;152:e173120. [PMID: 28903131 DOI: 10.1001/jamasurg.2017.3120] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
46 Kumar A, Purohit S, Sharma NK. Aberrant DNA Double-strand Break Repair Threads in Breast Carcinoma: Orchestrating Genomic Insult Survival. J Cancer Prev 2016;21:227-34. [PMID: 28053956 DOI: 10.15430/JCP.2016.21.4.227] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
47 Chatterjee A, Rodger EJ, Eccles MR. Epigenetic drivers of tumourigenesis and cancer metastasis. Semin Cancer Biol 2018;51:149-59. [PMID: 28807546 DOI: 10.1016/j.semcancer.2017.08.004] [Cited by in Crossref: 114] [Cited by in F6Publishing: 99] [Article Influence: 22.8] [Reference Citation Analysis]
48 Bhattacharya P, Patel TN. Microsatellite Instability and Promoter Hypermethylation of DNA repair genes in Hematologic Malignancies: a forthcoming direction toward diagnostics. Hematology 2018;23:77-82. [PMID: 28728506 DOI: 10.1080/10245332.2017.1354428] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
49 Tang RX, Chen WJ, He RQ, Zeng JH, Liang L, Li SK, Ma J, Luo DZ, Chen G. Identification of a RNA-Seq based prognostic signature with five lncRNAs for lung squamous cell carcinoma. Oncotarget 2017;8:50761-73. [PMID: 28881601 DOI: 10.18632/oncotarget.17098] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 6.4] [Reference Citation Analysis]